偉思醫療(688580.SH):減持期過半 僅陽和投資、連慶明減持合計15.23萬股
格隆匯11月12日丨偉思醫療(688580.SH)公佈,截至公吿日,陽和投資減持股份數量92,300股,減持股份數量佔公司總股本的0.14%;連慶明減持股份數量60,000股,減持股份數量佔公司總股本的0.09%;
蘇彩龍減持股份數量0股,減持股份數量佔公司總股本的0%;黎曉明減持股份數量0股,減持股份數量佔公司總股本的0%;石壯平減持股份數量0股,減持股份數量佔公司總股本的0%;譚飛減持股份數量0股,減持股份數量佔公司總股本的0%;楊崇祥減持股份數量0股,減持股份數量佔公司總股本的0%;周東耀減持股份數量0股,減持股份數量佔公司總股本的0%;鄭桂華減持股份數量0股,減持股份數量佔公司總股本的0%。
本次減持計劃時間已過半,減持計劃尚未實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.